Women with atrial fibrillation [18] or coronary atherosclerosis [19] present higher plasma FABP4 levels, whereas women with stable angina and chronic kidney disease exhibit reduced plasma FABP4 [20]. This evidence concerns the gene FABP4 and coronary atherosclerosis.